Legato Capital Management’s Corcept Therapeutics CORT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$351K	Buy	+8,716	New	+$326K	0.03%	605
2025 Q4	–	Sell	-17,982	Closed	-$1.49M	–	767
2025 Q3	$1.49M	Buy	17,982 +4,110	+30%	+$297K	0.16%	187
2025 Q2	$1.02M	Sell	13,872 -14,103	-50%	-$1.02M	0.12%	269
2025 Q1	$3.2M	Sell	27,975 -4,341	-13%	-$264K	0.43%	44
2024 Q4	$1.63M	Sell	32,316 -1,725	-5%	-$90.4K	0.21%	146
2024 Q3	$1.58M	Buy	34,041 +9,985	+42%	+$355K	0.19%	167
2024 Q2	$782K	Buy	24,056 +8,680	+56%	+$238K	0.11%	323
2024 Q1	$387K	Hold	15,376	–	–	0.05%	478
2023 Q4	$499K	Hold	15,376	–	–	0.07%	416
2023 Q3	$419K	Sell	15,376 -6,125	-28%	-$177K	0.06%	434
2023 Q2	$478K	Hold	21,501	–	–	0.06%	427
2023 Q1	$466K	Hold	21,501	–	–	0.08%	369
2022 Q4	$437K	Buy	+21,501	New	+$539K	0.08%	372